Dapagliflozin Improves Glycemic Control, Hypertension and is Neutral on Severe Renal Impairment in Uni-nephrectomized SDT fatty rat, a 10-week Model of Advanced Renal Complications and Glomerular Filtration Rate Decline.

Key Word:
Dapagliflozin, Glycemic Control, Hypertension, Renal Impairment, Uni-nephrectomized, Renal Complications, Glomerular Filtration Rate

François Briand¹, Masami Shinohara², Emmanuel Brousseau¹, Yasushi Kageyama², Thierry Sulpice¹

¹Physiogenex, Labège, France; ²CLEA Japan Inc. Meguro-ku, Tokyo, Japan

For more details, please click here (Google Search)

Related CLEA Japan product: SDT fatty/Jcl

For the animal model, please click here ▼

 https://www.clea-japan.com/en/products/diabetes/item_a0150

Inquiry

If you have any questions, please feel free to contact us.